Wednesday, February 13, 2013

• 3 Events Biotech Investors Need to Watch in 2013at Motley Fool (Wed, Feb 13)

Friday, January 11, 2013

• 4 Biotech Stocks With Insider Interestat Motley Fool (Fri, Jan 11)

Saturday, December 29, 2012

• 3 Things to Watch at Merrimackat Motley Fool (Sat, Dec 29)

Wednesday, December 19, 2012

• 2012 Review: Merrimack Pharmaceuticalsat Motley Fool (Wed, Dec 19)

Monday, December 17, 2012

• MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under anEDGAR Online (Mon, Dec 17)

Friday, December 14, 2012

• Here's What This $4 Billion Hedge Fund Has Been Buyingat Motley Fool (Fri, Dec 14)

Thursday, December 13, 2012

• Cancer Stocksat Forbes (Thu, Dec 13)
• 1 Catalyst Biotech Investors Need to Watchat Motley Fool (Thu, Dec 13)

Monday, December 10, 2012

• 'Mad Money' Lightning Round: Buy, Buy, Buy Cabella's, UnitedHealthcareat TheStreet (Mon, Dec 10)

Friday, December 7, 2012

• [video] Lightning Roundat CNBC (Fri, Dec 7)

Thursday, December 6, 2012

• Does Merrimack Pharmaceuticals Have A Blockbuster Drug With MM-398?at Seeking Alpha (Thu, Dec 6)
• 4 Biotechs With Poor Balance Sheetsat Seeking Alpha (Thu, Dec 6)

Monday, December 3, 2012

• Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012Marketwired (Mon, Dec 3)

Wednesday, November 14, 2012

• MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations aEDGAR Online (Wed, Nov 14)

Thursday, October 4, 2012

• Why Does Billionaire Thomas Steyer’s Farallon Love This Pharmaceutical Company?at Motley Fool (Thu, Oct 4)

Thursday, September 27, 2012

• Merrimack initiated with a Buy at Brean Murrayat theflyonthewall.com (Thu, Sep 27)

Tuesday, September 25, 2012

• U.S. Stocks Fall Amid Concern Over Stimulus Effortsat Bloomberg (Tue, Sep 25)

Saturday, September 22, 2012

• 5 Low-Debt Biotech Stocks Forecasted For Growthat Seeking Alpha (Sat, Sep 22)

Friday, September 21, 2012

• //C O R R E C T I O N//Myeloma Therapies, Hepatitis C Treatments, Colorectal Cancer Drugs, Phase III Trials for Hsp90 Inhibitor: Medical Breakthroughs are Powering Biotech Sector HigherWall Street Transcript (Fri, Sep 21)
• Colorectal Cancer Drug Regorafenib Receives Approval, Carfilzomib Approved for Myeloma Therapy, Hepatitis C Treatments, Phase III Trials for Hsp90 Inhibitor: Medical Breakthroughs are Powering Biotech Sector HigherWall Street Transcript (Fri, Sep 21)

Tuesday, September 18, 2012

• Tuesday 9/18 Insider Buying Report: MACK, DEIat Forbes (Tue, Sep 18)

Friday, September 14, 2012

• MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Fri, Sep 14)

Friday, August 31, 2012

• New Stock Coverage: Garmin Finds Its Wayat Minyanville (Fri, Aug 31)

Thursday, August 30, 2012

• MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Thu, Aug 30)

Wednesday, August 29, 2012

• 5 Healthcare Companies With Insider Buying Filed On August 24 - 28at Seeking Alpha (Wed, Aug 29)

Add MACK News to My Yahoo!